Cognitive impairment induced by benzodiazepine use disorder and its reversibility: a case report
DOI:
https://doi.org/10.20882/adicciones.767Keywords:
benzodiazepine, cognitive impairment.Abstract
Letter to the editor.References
Álvarez, F. J., González-Luque, J. C. y Seguí-Gómez, M. (2015). Drogas, Trastorno por Uso de Sustancias y Conducción: La intervención de los profesionales que trabajan en adicciones. Adicciones, 27, 161-167.
Baldwin, D., Woods, R., Lawson, R. y Taylor, D. (2011). Efficacy of drug treatments for generalised anxiety disorder; systematic review and meta-analysis. British Medical Journal, 342, d1199. doi:10.1136/bmj.d1199.
Barker, M. J., Greenwood, K. M., Jackson, M. y Crowe, S. F. (2004). Persistence of cognitive effects after withdrawal from long-term benzodiazepine use: a meta-analysis. Archives of Clinical Neuropsycholy, 19, 437-454.
Billioti de Gage, S., Bégaud, B., Bazin, F., Verdoux, H., Dartigues J. F., Pérès, K.,... Pariente, A. (2012). Benzodiazepine use and risk of dementia: prospective population based study. British Medical Journal, 345, e6231. doi:10.1136/bmj.e6231
Hadley, S. J., Mandel, F. S. y Schweizer, E. (2012). Switching from long-term benzodiazepine therapy to pregabalin in patients with generalized anxiety disorder: a double-blind, placebo-controlled trial. Journal of Psychopharmacology, 26, 461-470. doi:10.1177/0269881111405360.
Hollingworth, S. A. y Siskind, D. J. (2010). Anxiolytic, hypnotic and sedative medication use in Australia. Pharmacoepidemiology and Drug Safety, 19, 280-288. doi:10.1002/pds.1899.
Lader, M. (2012). Benzodiazepine harm: how can it be reduced? British Journal of Clinical Pharmacology, 77, 295-301. doi:10.1111/j.1365-2125.2012.04418.x
NICE. (2011). Anxiety. Generalised anxiety disorder and panic disorder (with or without agoraphobia) in adults. Clinical Guideline 113.
Oulis, P. y Konstantakopoulos, G. (2012). Efficacy and safety of pregabalin in the treatment of alcohol and benzodizepines dependence. Expert Opinion on Investigational Drugs, 21, 1019-1029. doi:10.1517/13543784.2012.685651.
Vicente, M. P., Sánchez, V., Macías, D., de la Fuente, C., González, D., Montero, D. y Catalá, F. (2013). Evolución del uso de medicamentos ansiolíticos en España durante el período 2000-2011. Revista Española de Salud Pública, 87, 247-255.
